SOX2, located on 3q26.3–q27, is identified as a major oncogene in OSCC [13], associated with tumor proliferation, metastasis, therapeutic resistance, and the facilitation of epithelial–mesenchymal transition (EMT) [17,22,23]. The gene discussed is SOX2; the disease is neoplasm.